MeSH tree: D04.345.674
A critical problem in treating Clostridioides difficile infections is the possibility that the pathogen develops resistance to fidaxomicin, an antibiotic often prescribed as a first-line treatment. But current methods used ...
Jun 5, 2026
0
3
Obesity is known to be a major risk factor that exacerbates metabolic disorders, such as type 2 diabetes. A key molecule involved in this process is endotrophin, a signaling protein that links excess fat accumulation to metabolic ...
Apr 1, 2026
0
7
As the effectiveness of antibiotics meant to fight the deadly superbug Clostridioides difficile, or C. diff, wanes, a research team at the University of Houston is seeing positive results of a new antibiotic on the scene—ibezapolstat—which ...
Sep 4, 2025
0
120
In a new Annals "Beyond the Guidelines" feature, an infectious diseases specialist and a gastroenterologist discuss the benefits and risks of different treatment approaches for Clostridioides difficile infection (CDI). The ...
Aug 8, 2023
0
41
Antibiotics help to fight bacterial infections, but they can also harm the helpful microbes living in the gut, which can have long-lasting health consequences.
Apr 16, 2023
0
78
